MEG3 and hepatocellular carcinoma: Knockdown of MEG3 promoted hepatoma cells (SMMC-7721 and BEL-7402) by activating the PI3K/AKT pathway through regulating adaptor-related protein complex 1 (AP1G1) (Sun et al., 2019).